Whatman expands FTA product family for biological materials

13 June 2004

Whatman Inc, a US separations technology company, has announced three new products within its Whatman FTA product range for the collection and customization of biological samples. The products, known as Whatman PlantSaver Card, Whatman FTA Kit and Whatman SPOT Holder, are used in field and laboratory collection of plant species, blood or buccal cells and bacterial clones.

The company notes that: Whatman FTA is a unique technology that allows for the safe and rapid isolation of pure DNA at room temperature: Whatman PlantSaver is a four-square version of the FTA card with a laminated flap that strengthens the card and makes it more robust and suitable for field collection and easy transport of plant samples; and the Whatman FTA Kit turns collection, storage, transportation, archiving and purification of nucleic acids into one complete solution with a kit that contains Micro cards, reagents and UniCore.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight